Facebook
Twitter
Telegram
Report an ErrorNavidea Biopharmaceuticals Financial Ratios 2011-2024 | NAVB
Annual Financial Ratios Navidea Biopharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.6 | -2.4 | -4.9 | -1.6 | -1.4 | 0.8 | -4.9 | -4.6 | -6.7 | -4.9 | -10.8 | 44.2 |
P/S |
136.5 | 53.6 | 56.9 | 26.5 | 19.0 | 32.1 | 3.2 | 9.5 | 38.2 | 186.4 | 4000.7 | 414.9 |
EPS |
-0.6 | -0.4 | -0.5 | -0.8 | -0.1 | 0.5 | -0.1 | -0.2 | -0.2 | -0.3 | -0.3 | 0.1 |
EV (Enterprise Value) |
19.5 M | 30.3 M | 55.1 M | 21.4 M | 23.3 M | 64.1 M | 149 M | 187 M | 276 M | 222 M | 319 M | 229 M |
EBITDA per Share |
-0.45 | -0.41 | -0.445 | -0.752 | -1.25 | -1.69 | -0.222 | -2.38 | -3.65 | -6.24 | -5.61 | -5.29 |
EV/EBITDA |
-0.1 | -4.7 | -1.5 | -1.8 | -4.2 | -75.5 | -10.0 | -9.9 | -5.4 | -11.4 | -9.4 | |
PEG |
0.03 | -0.02 | -2.45 | -0.03 | 0.01 | 0.0 | -0.1 | -0.18 | -0.21 | 0.24 | 0.02 | 0.41 |
P/B |
-1.1 | 45.6 | 39.6 | -10.8 | 12.7 | 5.1 | -1.0 | -2.3 | -8.0 | -52.6 | -224.1 | 11.7 |
P/CF |
-1.0 | -2.8 | -6.1 | -1.9 | 5.2 | 1.0 | 19.7 | -6.6 | -7.9 | -5.7 | -12.8 | -15.3 |
ROE % |
179.91 | 11009.17 | -814.96 | 679.05 | -924.95 | 658.60 | 21.00 | 50.76 | 119.87 | 1064.93 | 2074.69 | 26.56 |
ROA % |
-347.18 | -176.54 | -138.20 | -263.75 | -229.49 | 360.64 | -114.82 | -184.19 | -299.72 | -105.91 | -243.54 | 17.99 |
ROCE % |
166.56 | 11318.38 | -352.00 | -3308.39 | -297.76 | -109.16 | 3.87 | -211.27 | -978.13 | -132.43 | -484.09 | -86.57 |
Current Ratio |
0.3 | 1.1 | 1.4 | 0.8 | 1.7 | 1.7 | 0.2 | 2.0 | 0.9 | 3.3 | 1.7 | 9.0 |
DSO |
260.3 | 1057.7 | 1191.6 | 500.1 | 6.6 | 1640.7 | 29.9 | 102.0 | 47.5 | 371.5 | 81.6 | 9.6 |
DIO |
54392.6 | - | 59137.7 | - | - | - | 233.7 | 135.8 | 214.6 | 2448.3 | - | - |
DPO |
333206.4 | - | 404605.6 | 60882.7 | 1604.2 | 85480.9 | 1131.9 | 367.7 | 340.0 | 2656.6 | - | - |
Operating Cycle |
54652.9 | 1057.7 | 60329.3 | 500.1 | 6.6 | 1640.7 | 263.7 | 237.8 | 262.1 | 2819.8 | - | - |
Cash Conversion Cycle |
-278553.5 | 1057.7 | -344276.3 | -60382.6 | -1597.6 | -83840.2 | -868.2 | -129.8 | -77.9 | 163.2 | - | - |
All numbers in USD currency
Quarterly Financial Ratios Navidea Biopharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.02 | 0.12 | -0.05 | - | -0.25 | -0.1 | -0.1 | - | -0.08 | -0.09 | -0.11 | - | -0.13 | -0.11 | -0.13 | - | -0.17 | -0.24 | -0.24 | - | -0.02 | -0.02 | -0.83 | -0.03 | -0.01 | -0.03 | 0.53 | -0.03 | -0.07 | -0.04 | -0.02 | -0.02 | -0.05 | -0.06 | -0.05 | -0.05 | -0.05 | -0.07 | -0.08 | -0.1 | -0.09 | -0.09 | -0.06 | -70 | -90 | -60 | -70 | - | 0.21 | -0.02 | -0.05 |
EBITDA per Share |
-0.02 | -0.05 | -0.07 | - | -0.16 | -0.1 | -0.1 | - | -0.08 | -0.09 | -0.12 | - | -0.11 | -0.1 | -0.13 | - | -0.16 | -0.23 | -0.24 | - | -0.02 | -0.01 | -0.3 | -0.02 | -0.01 | -0.03 | -0.02 | -0.02 | - | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 | -0.04 | -0.03 | -0.03 | -0.06 | -0.06 | -0.1 | -0.08 | -0.07 | -0.06 | -0.06 | -0.09 | -0.06 | -0.07 | - | -0.07 | -0.04 | -0.05 |
ROE % |
-352.29 | -298.91 | 330.79 | 334.64 | 275.67 | 94.40 | -17.87 | -159.75 | -380.13 | -541.54 | -676.77 | -600.38 | -409.71 | 1.34 | 343.91 | 507.13 | 287.75 | -122.30 | -425.52 | -743.56 | -779.22 | -572.05 | -480.22 | 658.60 | 699.96 | 712.25 | 767.64 | 21.00 | 19.93 | 34.70 | 42.74 | 50.76 | 69.17 | 77.45 | 93.91 | 119.87 | 439.82 | 698.64 | 921.23 | 1064.92 | 1234.48 | 1599.92 | 1758.21 | 2072.43 | 1653.75 | 1100.19 | 674.65 | 62.56 | 93.85 | -10.36 | -20.93 |
ROA % |
-119.75 | -171.38 | -364.56 | -293.93 | -321.14 | -257.15 | -161.05 | -80.35 | -117.73 | -127.89 | -134.16 | -101.81 | -175.87 | -212.56 | -246.98 | -196.98 | -251.41 | -231.78 | -201.48 | -184.49 | -204.02 | -156.27 | -147.14 | 360.64 | 349.01 | 355.22 | 326.57 | -114.82 | -100.44 | -153.90 | -165.05 | -184.19 | -225.45 | -229.83 | -251.48 | -301.25 | -277.33 | -247.05 | -186.19 | -105.91 | -131.96 | -179.92 | -203.10 | -243.27 | -119.53 | 20.04 | 61.76 | 42.38 | 63.58 | -7.02 | -14.18 |
ROCE % |
421.55 | 462.50 | 306.45 | 316.23 | 257.65 | 92.99 | -17.41 | -166.54 | -386.86 | -548.61 | -685.04 | -601.29 | -409.98 | 1.65 | 345.31 | 508.00 | 294.40 | -110.50 | -415.47 | -496.27 | -527.21 | -334.58 | -237.75 | -121.96 | -86.26 | -63.96 | -18.28 | 14.90 | 16.52 | 24.23 | 27.28 | 33.96 | 42.60 | 51.55 | 76.13 | 92.72 | 403.25 | 632.78 | 812.76 | 958.65 | 1133.04 | 1530.82 | 1703.24 | 1991.50 | 1460.93 | 784.99 | 384.70 | -71.28 | -30.63 | -16.98 | -23.67 |
Current Ratio |
0.7 | 0.9 | 0.2 | 0.3 | 0.6 | 0.4 | 0.6 | 1.1 | 1.9 | 2.3 | 2.0 | 1.4 | 1.4 | 1.4 | 1.4 | 0.8 | 0.8 | 0.8 | 0.8 | 1.5 | 1.5 | 1.5 | 1.5 | 2.4 | 2.4 | 2.4 | 2.4 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 3.1 | 3.1 | 3.1 | 3.1 |
DSO |
- | - | - | - | - | - | - | - | - | - | 1101.5 | - | - | 285.3 | 758.1 | - | 68.0 | 194.4 | 1011.2 | - | 8.3 | 3.6 | 1346.6 | - | 3320.0 | 1214.2 | 656.1 | - | 10.2 | 15.9 | 10.3 | - | 42.9 | 70.7 | 50.4 | 71.3 | 94.6 | 71.2 | 143.2 | 174.1 | 415.1 | 821.4 | - | - | - | - | - | - | 365.7 | 29.3 | - |
DIO |
- | - | - | - | 16232.4 | 61604.6 | - | - | - | - | - | - | 188952.0 | 43400.8 | 12720.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | 132706.6 | 385023.4 | - | - | - | - | - | - | 1292764.3 | 296937.5 | 170347.3 | - | 520391.3 | 426371.0 | 11445.6 | - | 1017.2 | 1095.0 | 183613.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | 16232.4 | 61604.6 | - | - | - | - | 1101.5 | - | 188952.0 | 43686.1 | 13479.1 | - | 68.0 | 194.4 | 1011.2 | - | 8.3 | 3.6 | 1346.6 | - | 3320.0 | 1214.2 | 656.1 | - | 10.2 | 15.9 | 10.3 | - | 42.9 | 70.7 | 50.4 | 71.3 | 94.6 | 71.2 | 143.2 | 174.1 | 415.1 | 821.4 | - | - | - | - | - | - | 365.7 | 29.3 | - |
Cash Conversion Cycle |
- | - | - | - | -116474.2 | -323418.8 | - | - | - | - | 1101.5 | - | -1103812.3 | -253251.4 | -156868.2 | - | -520323.3 | -426176.6 | -10434.5 | - | -1008.8 | -1091.5 | -182266.9 | - | 3320.0 | 1214.2 | 656.1 | - | 10.2 | 15.9 | 10.3 | - | 42.9 | 70.7 | 50.4 | 71.3 | 94.6 | 71.2 | 143.2 | 174.1 | 415.1 | 821.4 | - | - | - | - | - | - | 365.7 | 29.3 | - |
All numbers in USD currency